false
2026-11-10
0002066836
Conexeu Sciences Inc.
0002066836
2026-11-10
2026-11-10
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
November 10, 2026
CONEXEU SCIENCES INC.
(Exact name of registrant as specified in its charter)
|
Nevada
|
001-43283
|
33-4814282
|
| (State or other jurisdiction |
(Commission |
(IRS Employer |
| of incorporation) |
File Number) |
Identification No.) |
50 West Liberty Street, Suite 880,
Reno, Nevada, United States
89501
(Address of principal executive offices) (ZIP Code)
Registrant's telephone number, including area code: (424) 333-5622
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
|
Trading Symbols |
|
Name of each exchange on which registered |
|
Common Stock
|
|
CNXU
|
|
The Nasdaq Stock Market LLC
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b -2 of this chapter).
Emerging growth company ☑
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
SECTION 8 - OTHER EVENTS
Item 8.01 Other Events
On November 10, 2026, Conexeu Sciences Inc. (the "Company") filed a Notice of Meeting and Record Date for its Special Meeting of Stockholders to be held on January 26, 2027 on the System for Electronic Document Analysis and Retrieval with the British Columbia Securities Commission in Canada in accordance with the requirements of the Canadian Securities Administrators National Instrument 54-101 - Communication with Beneficial Owners of Securities of a Reporting Issuer as the Company is a reporting issuer in British Columbia, Canada.
A copy of the Notice of Meeting and Record Date is filed as Exhibit 99.1 hereto.
SECTION 9 - FINANCIAL STATEMENTS AND EXHIBITS
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
| Exhibit |
|
Description |
| 99.1 |
|
Notice of Meeting and Record Date |
| 104 |
|
Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
CONEXEU SCIENCES INC. |
| DATE: November 16, 2026 |
By: /s/ Stephen Inouye Stephen Inouye CFO, Secretary and Treasurer |
CONEXEU SCIENCES INC.
November 10, 2026
All Canadian Securities Regulatory Authorities
Dear Sirs:
Re: Special Meeting of Conexeu Sciences Inc.
Conexeu Sciences Inc., a Nevada corporation, whose common stock is registered under section 12(b) of the United States Securities Exchange Act of 1934, as amended, advises of the following with respect to the upcoming meeting of security holders:
| Company: |
Conexeu Sciences Inc. |
| Meeting Type: |
Special Meeting |
CUSIP#: ISIN#: |
20715F100 US20715F1003 |
| Class of Security entitled to receive Notice: |
Common |
| Class of Security entitled to vote at Meeting: |
Common |
| Record Date for Notice: |
December 8, 2026 |
| Record Date for Voting: |
December 8, 2026 |
| Beneficial Ownership Determination Date: |
December 8, 2026 |
| Meeting Date: |
January 26, 2027 |
| Place of Meeting: |
Suite 1500, 1055 West Georgia Street, Vancouver, British Columbia, Canada |
| Company sending materials directly to NOBOs: |
No |
| Company to pay for delivery of materials to OBOs: |
Yes |
| Notice-and-Access for Registered Holders: |
Yes |
| Notice and Access for Beneficial Holders: |
Yes |
If you require further information, please contact the undersigned.
Yours truly,
CONEXEU SCIENCES INC.
Per "Stephen Inouye"
Stephen Inouye,
Chief Financial Officer